Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S1) is a recombinant antigen which contains the Spike protein amino acids 1-674. Spike S1 protein is manufactured in HEK293 mammalian cells, ensuring the most authentic post-translational modifications.
Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike S2 protein, amino acids 685-1211. Spike S2 is manufactured in mammalian HEK293 cells to ensure the most authentic post-translational modifications.
We explore the importance of cleanrooms in life science labs, and discuss challenges and considerations for cleanroom design
New blood test provides a unique new framework for early detection of the most common cancers
With abundant data on plants, large animals and their activity, and carbon soil levels in the Amazon, Stanford research suggests that large animal diversity influences carbon stocks and contributes to climate change mitigation
SARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike protein amino acids 685-1211 of subunit 2. Spike S2 protein is manufactured to high yield and purity using the Native Antigens baculovirus-insect cell platform. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Chromatographic method development factors, parameters and strategies
A look at some of the available companion diagnostics for breast, lung and colorectal cancer
Chromatography experts share how the latest 2D-LC technology can benefit your pharmaceutical, food, or polymer analysis applications and more
A mass spectrometry breath test, artificial intelligence algorithms and novel anti-inflammatory compounds among the innovations that could pave the way for better diagnoses and treatment
Register now to join world-leading researchers online, March 31-April 2, as the global science industry pulls together at this critical time
Read this exclusive interview with Louise Kenny, one of the founding directors of the INFANT Centre, to discover how they are using mass spectrometry to research preeclampsia and pre-term birth
Dr. Josephine Bunch, UK Grand Challenge awardee, describes her unprecedented research into a tumor’s intricate architecture and shares her ultimate goal of mapping what’s inside a tumor
AEOL 10150 is currently the only drug being developed by BARDA to address the delayed effects of radiation exposure
The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4 genetic variant using a simple blood sample
From smarter data capture to predictive analysis, next‑generation R&D data platforms are streamlining complexity and accelerating decision‑making across the lab
Multiplex PCR assay enables beverage microbiology labs to accelerate product release testing by up to six days
Against a backdrop of rising global obesity, researchers trace brown fat to an unexpected embryonic source
Compact, all-in-one mass photometer helps researchers verify sample quality before proceeding to cryo-EM, native MS, BLI, SPR, and other costly experiments
Using just a few drops of blood from a finger prick, the test can help guide treatment decisions in 15 minutes – reducing unnecessary antibiotic use, detecting bacterial infections that may otherwise be missed, and ultimately improving patient outcomes
